Screening: Screening for kidney disease--a lost opportunity

Area of Science:

• Nephrology
• Clinical Practice Guidelines

Background:

• The American College of Physicians (ACP) released guidelines for screening chronic kidney disease (CKD).
• These guidelines were developed with limited or no data.
• Kidney disease experts were not involved in the guideline creation process.

Purpose of the Study:

• To inform health professionals about the limitations of the current ACP kidney disease screening guidelines.
• To highlight potential risks to patients due to inadequate screening protocols.
• To emphasize the importance of expert involvement in developing clinical practice guidelines.

Main Methods:

• Analysis of the ACP guidelines for kidney disease screening.
• Review of the evidence base used for guideline development.
• Assessment of the potential impact on patient care and outcomes.

Main Results:

• The ACP guidelines are characterized as 'weak' due to insufficient supporting data.
• The lack of expert nephrologist input raises concerns about the guidelines' clinical applicability.
• There is a potential risk of harm to patients with undiagnosed or progressive kidney disease.

Conclusions:

• Health professionals should be aware of the significant limitations and potential harms associated with the current ACP kidney disease screening guidelines.
• The absence of kidney disease expert consultation during guideline development is a critical flaw.
• Further development of evidence-based, expert-driven guidelines is crucial for effective kidney disease screening and patient management.